Summit Street Capital Management, LLC United Therapeutics Corp Transaction History

Summit Street Capital Management, LLC

$274 Million
Q2 2024

A detailed history of Summit Street Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Summit Street Capital Management, LLC holds 36,431 shares of UTHR stock, worth $13.6 Million. This represents 4.24% of its overall portfolio holdings.

Number of Shares

36,431

Previous 34,139 6.71%

Holding current value

$13.6 Million

Previous $7.84 Million 47.99%

% of portfolio

4.24%

Previous 3.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $523,171 - $731,239	2,292 Added 6.71%	36,431 $11.6 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $1.07 Million - $1.27 Million	5,098 Added 17.55%	34,139 $7.84 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $1.78 Million - $2.14 Million	-8,764 Reduced 23.18%	29,041 $6.08 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $501,844 - $570,011	-3,260 Reduced 7.94%	37,805 $6.32 Million
Q2 2020 Aug 17, 2020	SELL	$92.74 - $125.82 $207,644 - $281,710	-2,239 Reduced 5.17%	41,065 $4.97 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $241,821 - $351,356	3,046 Added 7.57%	43,304 $4.11 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $1.84 Million - $2.24 Million	-23,537 Reduced 36.89%	40,258 $3.55 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $1.76 Million - $2.03 Million	23,564 Added 58.57%	63,795 $5.09 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $684,768 - $1.09 Million	9,003 Added 28.83%	40,231 $3.14 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $770,301 - $911,852	7,189 Added 29.91%	31,228 $3.67 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $987,534 - $1.25 Million	-9,739 Reduced 28.83%	24,039 $2.62 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $370,779 - $433,724	3,666 Added 12.17%	33,778 $3.82 Million
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $428,518 - $607,304	3,997 Added 15.31%	30,112 $3.38 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $2.99 Million - $3.57 Million	26,115	26,115 $3.06 Million

Others Institutions Holding UTHR

# of Institutions

637

Shares Held

44.9M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Street Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Street Capital Management, LLC with notifications on news.

Account

Summit Street Capital Management, LLC United Therapeutics Corp Transaction History